FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095064953> ?p ?o ?g. }

• W2095064953 endingPage "3242" @default.
• W2095064953 startingPage "3227" @default.
• W2095064953 abstract "Eleven new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivatives [tacrine (THA)−huperzine A hybrids, rac-21−31] have been synthesized as racemic mixtures and tested as acetylcholinesterase (AChE) inhibitors. For derivatives unsubstituted at the benzene ring, the highest activity was obtained for the 9-ethyl derivative rac-20, previously prepared by our group. More bulky substituents at position 9 led to less active compounds, although some of them [9-isopropyl (rac-22), 9-allyl (rac-23), and 9-phenyl (rac-26)] show activities similar to that of THA. Substitution at position 1 or 3 with methyl or fluorine atoms always led to more active compounds. Among them, the highest activity was observed for the 3-fluoro-9-methyl derivative rac-28 [about 15-fold more active than THA and about 9-fold more active than (−)-huperzine A]. The activity of some THA−huperzine A hybrids (rac-19, rac-20, rac-28, and rac-30), which were separated into their enantiomers by chiral medium-pressure liquid chromatography (chiral MPLC), using microcrystalline cellulose triacetate as the chiral stationary phase, showed the eutomer to be always the levorotatory enantiomer, their activity being roughly double that of the corresponding racemic mixture, the distomer being much less active. Also, the activity of some of these compounds inhibiting butyrylcholinesterase (BChE) was tested. Most of them [rac-27−31, (−)-28, and (−)-30], which are more active than (−)-huperzine A as AChE inhibitors, turned out to be quite selective for AChE, although not so selective as (−)-huperzine A. Most of the tested compounds 19−31 proved to be much more active than THA in reversing the neuromuscular blockade induced by d-tubocurarine. Molecular modeling of the interaction of these compounds with AChE from Torpedo californica showed them to interact as truly THA−huperzine A hybrids: the 4-aminoquinoline subunit of (−)-19 occupies the same position of the corresponding subunit in THA, while its bicyclo[3.3.1]nonadiene substructure roughly occupies the same position of the corresponding substructure in (−)-huperzine A, in agreement with the absolute configurations of (−)-19 and (−)-huperzine A." @default.
• W2095064953 created "2016-06-24" @default.
• W2095064953 creator A5006399866 @default.
• W2095064953 creator A5008514402 @default.
• W2095064953 creator A5009669588 @default.
• W2095064953 creator A5026096206 @default.
• W2095064953 creator A5037789245 @default.
• W2095064953 creator A5049250189 @default.
• W2095064953 creator A5056898386 @default.
• W2095064953 creator A5058817123 @default.
• W2095064953 creator A5059104366 @default.
• W2095064953 creator A5060163707 @default.
• W2095064953 creator A5076431782 @default.
• W2095064953 date "1999-07-30" @default.
• W2095064953 modified "2023-10-17" @default.
• W2095064953 title "Synthesis, in Vitro Pharmacology, and Molecular Modeling of Very Potent Tacrine−Huperzine A Hybrids as Acetylcholinesterase Inhibitors of Potential Interest for the Treatment of Alzheimer's Disease" @default.
• W2095064953 cites W1530873460 @default.
• W2095064953 cites W1971048984 @default.
• W2095064953 cites W1974092275 @default.
• W2095064953 cites W1976216957 @default.
• W2095064953 cites W1980639857 @default.
• W2095064953 cites W1985026342 @default.
• W2095064953 cites W1986224259 @default.
• W2095064953 cites W1997639796 @default.
• W2095064953 cites W2005453961 @default.
• W2095064953 cites W2006489170 @default.
• W2095064953 cites W2007860556 @default.
• W2095064953 cites W2012076046 @default.
• W2095064953 cites W2013350002 @default.
• W2095064953 cites W2015918154 @default.
• W2095064953 cites W2025664076 @default.
• W2095064953 cites W2027810744 @default.
• W2095064953 cites W2027978582 @default.
• W2095064953 cites W2032518125 @default.
• W2095064953 cites W2032687169 @default.
• W2095064953 cites W2035043090 @default.
• W2095064953 cites W2035199159 @default.
• W2095064953 cites W2045392136 @default.
• W2095064953 cites W2057931551 @default.
• W2095064953 cites W2073637781 @default.
• W2095064953 cites W2075369230 @default.
• W2095064953 cites W2080523080 @default.
• W2095064953 cites W2085958374 @default.
• W2095064953 cites W2086758152 @default.
• W2095064953 cites W2092677781 @default.
• W2095064953 cites W2104227586 @default.
• W2095064953 cites W2107029002 @default.
• W2095064953 cites W2110765139 @default.
• W2095064953 cites W2124540184 @default.
• W2095064953 cites W2150573845 @default.
• W2095064953 cites W2344563485 @default.
• W2095064953 cites W2949456685 @default.
• W2095064953 cites W2950060639 @default.
• W2095064953 cites W2953341487 @default.
• W2095064953 cites W4232004116 @default.
• W2095064953 cites W4242215325 @default.
• W2095064953 cites W4243892484 @default.
• W2095064953 doi "https://doi.org/10.1021/jm980620z" @default.
• W2095064953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10464010" @default.
• W2095064953 hasPublicationYear "1999" @default.
• W2095064953 type Work @default.
• W2095064953 sameAs 2095064953 @default.
• W2095064953 citedByCount "87" @default.
• W2095064953 countsByYear W20950649532012 @default.
• W2095064953 countsByYear W20950649532013 @default.
• W2095064953 countsByYear W20950649532014 @default.
• W2095064953 countsByYear W20950649532015 @default.
• W2095064953 countsByYear W20950649532016 @default.
• W2095064953 countsByYear W20950649532017 @default.
• W2095064953 countsByYear W20950649532018 @default.
• W2095064953 countsByYear W20950649532019 @default.
• W2095064953 countsByYear W20950649532020 @default.
• W2095064953 countsByYear W20950649532022 @default.
• W2095064953 countsByYear W20950649532023 @default.
• W2095064953 crossrefType "journal-article" @default.
• W2095064953 hasAuthorship W2095064953A5006399866 @default.
• W2095064953 hasAuthorship W2095064953A5008514402 @default.
• W2095064953 hasAuthorship W2095064953A5009669588 @default.
• W2095064953 hasAuthorship W2095064953A5026096206 @default.
• W2095064953 hasAuthorship W2095064953A5037789245 @default.
• W2095064953 hasAuthorship W2095064953A5049250189 @default.
• W2095064953 hasAuthorship W2095064953A5056898386 @default.
• W2095064953 hasAuthorship W2095064953A5058817123 @default.
• W2095064953 hasAuthorship W2095064953A5059104366 @default.
• W2095064953 hasAuthorship W2095064953A5060163707 @default.
• W2095064953 hasAuthorship W2095064953A5076431782 @default.
• W2095064953 hasBestOaLocation W20950649532 @default.
• W2095064953 hasConcept C181199279 @default.
• W2095064953 hasConcept C185592680 @default.
• W2095064953 hasConcept C2776409846 @default.
• W2095064953 hasConcept C2778816929 @default.
• W2095064953 hasConcept C2779046751 @default.
• W2095064953 hasConcept C2779059548 @default.
• W2095064953 hasConcept C2779101902 @default.
• W2095064953 hasConcept C31896038 @default.
• W2095064953 hasConcept C486523 @default.
• W2095064953 hasConcept C55493867 @default.
• W2095064953 hasConcept C71240020 @default.

• next